VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 18 filers reported holding VECTIVBIO HLDG AG in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $30,725,023 | +6.2% | 3,610,461 | +8.1% | 2.03% | +12.2% |
| Q4 2022 | $28,919,931 | +44.3% | 3,339,484 | 0.0% | 1.81% | +89.1% |
| Q3 2022 | $20,037,000 | +11.1% | 3,339,484 | 0.0% | 0.96% | +7.5% |
| Q2 2022 | $18,033,000 | +13.3% | 3,339,484 | -1.2% | 0.89% | +5.7% |
| Q1 2022 | $15,922,000 | -7.9% | 3,380,402 | -4.0% | 0.84% | +2.6% |
| Q4 2021 | $17,293,000 | -36.4% | 3,522,019 | 0.0% | 0.82% | -41.7% |
| Q3 2021 | $27,190,000 | -33.8% | 3,522,019 | 0.0% | 1.41% | -22.8% |
| Q2 2021 | $41,067,000 | – | 3,522,019 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 3,084,310 | $14,527,000 | 6.18% |
| Novo Holdings A/S | 3,380,402 | $15,922,000 | 0.84% |
| Cormorant Asset Management, LP | 2,078,485 | $9,790,000 | 0.75% |
| Orbimed Advisors | 5,330,704 | $25,108,000 | 0.41% |
| Bpifrance SA | 2,806,217 | $13,217,000 | 0.37% |
| Eventide Asset Management | 2,339,044 | $10,994,000 | 0.17% |
| Tekla Capital Management LLC | 756,502 | $3,556,000 | 0.12% |
| Canaan Partners XI LLC | 37,051 | $175,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 393,365 | $1,849,000 | 0.02% |
| Citadel Advisors | 2,722,646 | $12,797,000 | 0.00% |